Kiniksa Pharmaceuticals
KNSA
#4663
Rank
$1.42 B
Marketcap
🇧🇲 Bermuda
Country
$20.08
Share price
3.61%
Change (1 day)
46.68%
Change (1 year)
Categories
Kiniksa Pharmaceuticals (KNSA) - Total assets
Total assets on the balance sheet as of March 2024 : $0.51 B
According to Kiniksa Pharmaceuticals 's latest financial reports the company's total assets are $0.51 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Kiniksa Pharmaceuticals - Total assets on balance sheet (from 2017 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.52 B | 14.5% |
| 2022-12-31 | $0.45 B | 97.45% |
| 2021-12-31 | $0.23 B | -33.38% |
| 2020-12-31 | $0.34 B | 37.3% |
| 2019-12-31 | $0.25 B | -20.94% |
| 2018-12-31 | $0.32 B | 577.94% |
| 2017-12-31 | $47.49 M | -15.89% |
| 2016-12-31 | $56.46 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.25 B | -51.51% | 🇺🇸 USA |